Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial

Nat Med. 2024 Dec;30(12):3780. doi: 10.1038/s41591-024-03349-0.
No abstract available

Publication types

  • Published Erratum